These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9247790)

  • 21. Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study.
    Delmez JA; Kelber J; Norword KY; Giles KS; Slatopolsky E
    Kidney Int; 1996 Jan; 49(1):163-7. PubMed ID: 8770963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium-PTH relationship in dialysis patients: the pitfalls of using a constant dialysate calcium concentration during the dynamic tests.
    De Cristofaro V; Samà F; Pagliari B; Colturi C; Sidoti A; Masa A; Filippini M; Comelli M; Pedrini L
    Clin Nephrol; 1998 Feb; 49(2):113-20. PubMed ID: 9524782
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypercalcemia with calcium carbonate for uraemic hyperparathyroidism: consequence of a challenge overmet by the nephrologist?
    Fournier A
    Nephrol Dial Transplant; 1993; 8(2):188-9. PubMed ID: 8384346
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of reduced dialysate calcium on mineral metabolism in hemodialysis patients].
    Fujimori A; Yorifuji M; Sakai M; Fukagawa M
    Clin Calcium; 2005 Sep; 15 Suppl 1():121-4; discussion 124. PubMed ID: 16272643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term effect of low calcium dialysate on parathyroid activity in dialysis patients treated with calcium carbonate as a phosphate binder.
    Malberti F; Montoli A; Surian M
    Nephrol Dial Transplant; 1989; 4(8):758-9. PubMed ID: 2510088
    [No Abstract]   [Full Text] [Related]  

  • 26. [Optimum calcium concentration in the dialysate].
    Nakazawa R
    Clin Calcium; 2004 Sep; 14(9):84-7. PubMed ID: 15577117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence of hypercalcaemia in haemodialysis patients.
    Pascual N; Andrea C; Zaleski M; Hernandez J; Goicoechea M
    EDTNA ERCA J; 1997; 23(3):48-50. PubMed ID: 9664010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal composition of the dialysate, with emphasis on its influence on blood pressure.
    Locatelli F; Covic A; Chazot C; Leunissen K; Luño J; Yaqoob M
    Nephrol Dial Transplant; 2004 Apr; 19(4):785-96. PubMed ID: 15031331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
    Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
    Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of lowering dialysate calcium concentration on mineral metabolism and parathyroid hormone secretion: a multicentric study.
    Lezaic V; Pejanovic S; Kostic S; Pljesa S; Dimkovic N; Komadina L; Jovanovic D; Marinkovic J; Djukanovic L
    Ther Apher Dial; 2007 Apr; 11(2):121-30. PubMed ID: 17381533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients.
    Saab G; Young DO; Gincherman Y; Giles K; Norwood K; Coyne DW
    Nephron Clin Pract; 2007; 105(3):c132-8. PubMed ID: 17228173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study.
    Gubensek J; Buturovic-Ponikvar J; Ponikvar R
    Blood Purif; 2007; 25(5-6):454-6. PubMed ID: 18057876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dialysate calcium concentration ofKyriazis J; Glotsos J
    Nephron; 2000 Jan; 84(1):85-6. PubMed ID: 10644916
    [No Abstract]   [Full Text] [Related]  

  • 34. Iatrogenic hypercalcaemia--a case report.
    Deshpande MM
    J Indian Med Assoc; 2009 Mar; 107(3):173. PubMed ID: 19810388
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of ascorbate-rich dialysate to attenuate oxidative stress in maintenance hemodialysis patients.
    Shi XF; Ding F; Zhu QY; Xue J; Lu FM; Gu Y; Lin ST
    Ren Fail; 2005; 27(2):213-9. PubMed ID: 15807188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Efficacy of calcium carbonate as a phosphorus-chelating agent in hemodialysis patients].
    Almirall J; Campistol JM; Torras A; López-Pedret J; Revert L
    Med Clin (Barc); 1988 Oct; 91(11):409-12. PubMed ID: 3226185
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver granulomatosis is not an exceptional cause of hypercalcemia with hypoparathyroidism in dialysis patients.
    Hardy P; Morinière PH; Tribout B; Hamdini N; Marié A; Bouffandeau B; Pruna A; Fournier A
    J Nephrol; 1999; 12(6):398-403. PubMed ID: 10626831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
    Elsharkawy MM; Youssef AM; Zayoon MY
    Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antihypertensive effect of low calcium dialysis.
    Katzir Z; Michlin A; Boaz M; Biro A; Smetana S
    Isr Med Assoc J; 2005 Nov; 7(11):704-7. PubMed ID: 16308992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reappraisal of 2003 NKF-K/DOQI guidelines for management of hyperparathyroidism in chronic kidney disease patients.
    Monge M; Shahapuni I; Oprisiu R; El Esper N; Morinière P; Massy Z; Choukroun G; Fournier A
    Nat Clin Pract Nephrol; 2006 Jun; 2(6):326-36. PubMed ID: 16932454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.